Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

emicizumab 4 voxelotor 1 romiplostim 1 recombinant FVIIa 1 olaparib 1 maltodextrin 1 lusutrombopag 1 luspatercept 1 ibrutinib 1 fludarabine phosphate 1 continuous erythropoietin receptor activator 1 betrixaban 1 anti-inhibitor coagulant complex 1 Rituximab 1 Pharmacogenomic Testing 1 Glutamine 1 Factor VIII 1 Enoxaparin 1 Cyclophosphamide 1 CT-P10 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Factor VIII × Classical hematology × Clear all

NCT02847637 2022-11-16

HAVEN 3

Hoffmann-La Roche

Phase 3 Completed

152 enrolled 46 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡